Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025
Important purchasing considerations It is vital to distinguish between Melanotan 1 and Melanotan 2
Waiting for it while carrying excess weight that is damaging your cardiovascular system, joints, and metabolic health is not a neutral choice
10.1210/en.2018-00004 177
Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
just steady energy and metabolic support from intermittent infusions
